Skip to content

A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administration of 2% and 4% lidocaine gel into the urethra

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525752-29-00
Enrollment
28
Registered
2026-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bioavailability trial with healthy participants, therapeutic indication not studied

Interventions

None listed

Sponsors

Farco-Pharma GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: May 6, 2026